Pharma & Biotech News #PharmaBuzz

Market Place

Sourcing Support

Weekly News Recap #Phispers

FDA okays Vertex's non-opioid painkiller, Supernus' wearable device for Parkinson's; Sanofi, GSK plan share buybacks

While the healthcare sector in the US was embroiled in political uncertainties over tariffs and key appointments, the country&r...

Impressions : 455

FDA approves Ozempic to treat CKD in diabetes patients; AbbVie, Neomorph ink US$ 1.64 bn deal for molecular glue degraders

Novo Nordisk’s Ozempic became the first glucagon-like peptide 1 (GLP-1) drug to receive the US Food and Drug Administrati...

Impressions : 728

Trump withdraws US from WHO; Novo's Ozempic, Wegovy among 15 new drugs chosen for price negotiations under IRA

On the day Donald Trump was sworn in as the 47th President of the United States, there was a deluge of some 200 measures, which...

Impressions : 1367

J&J buys Intra-Cellular for US$ 14.6 bn; FTC exposes PBMs' US$ 7.3 bn drug price markup scheme

The week saw the J.P. Morgan Healthcare Conference kick off with a flurry of deals. In all, deals worth over US$ 19.3 billion ...

Impressions : 730

Only few entries up to this point, click to access all

Quality Compliance Alerts #Warning!

All News #Library

Generics

Biotech

APIs

Quality

Sciences

Rare Diseases

Others

NEWS

DRUGS & DEVELOPMENTS

MARKET INTEL by PharmaCompass

FDA okays Vertex's non-opioid painkiller, Supernus' wearable device for Parkinson's; Sanofi, GSK plan share buybacks

FDA approves Ozempic to treat CKD in diabetes patients; AbbVie, Neomorph ink US$ 1.64 bn deal for molecular glue degraders

Trump withdraws US from WHO; Novo's Ozempic, Wegovy among 15 new drugs chosen for price negotiations under IRA

J&J buys Intra-Cellular for US$ 14.6 bn; FTC exposes PBMs' US$ 7.3 bn drug price markup scheme

Saba's Generics Azilsartan Receive Tentative Approval in US

Natco Pharma's Generics Bosentan Receives Approval in US

Gland's Generics Methylnaltrexone Br Receive Tentative Approval in US

Square Pharma's Generics Methimazole Receives Approval in US

Mylan Pharma's Biologic Hulio Receives Suppl Approval in US

Genentech's Biologic Susvimo Receives Suppl Approval in US

Dr. Reddy's Generics Linagliptin Receive Tentative Approval in US

Torrent Pharm's Generics Ranolazine Receives Approval in US

Caplin's Generics Procainamide HCl Receives Approval in US

Mylan's Generics Dabigatran Receives Approval in US

Super's Diana Fails EDQM inspection

Enforcement Report - Week of February 5, 2025

Imperial Palace Commodity Receives FDA Warning Letter

Global Calcium Receives FDA Warning Letter

Shantou Kangjie Receives FDA Warning Letter

Center for Instrumental Analysis Receives FDA Warning Letter

Alvogen Issues Voluntary Nationwide Recall for Fentanyl Transdermal

Enforcement Report - Week of January 29, 2025

Kardesler Ucan Yaglar Receives FDA Warning Letter

Evolutionary Biologics Receives FDA Warning Letter

Belgian regulator recommends blocking Indian API production

Senators ask FDA to dig into 'misleading' Super Bowl ad from Hims

Glenmark, Cosmo get MHRA nod to acne treatment in UK

Sanofi launches Rezurock against chronic Graft-versus-host disease

Biovet gets CDSCO nod for lumpy skin disease vaccine

TB, malaria, newborn health services must restart, says USAID memo

Trump recall of CDC research puts scientific papers in limbo

Anuh Pharma standalone net profit declines 45.89% in the Dec 2024

Link Pharma reports standalone loss of Rs 0.67 crore in Dec 2024

Aurobindo approves acquisition of 80% stake in Tergene Biotech

Vaishali Pharma standalone profit declines 31.75% in Dec 2024

Genentech's Gazyva Shows Superiority in Active Lupus Nephritis

Lupin receives tentative FDA approval for generic Darunavir

Cosette Pharma Appoints Brad as VP, Generics Commercial Operation

A.forall Launches Tromethamine Injection With CGT Exclusivity

China+1 Boosts India's Share In Pharma Beyond Generics

Lupin gets USFDA nod for generic HIV drug

Piramal Launches Chlorpromazine Hydrochloride Injection In US

Piramal Pharma launches Chlorpromazine Hydrochloride in US

Sunshine Biopharma launches Olanzapine and Olanzapine ODT

Biovet gets CDSCO nod for lumpy skin disease vaccine

Aurobindo approves acquisition of 80% stake in Tergene Biotech

Novo's Bispecific for Hemophilia Aces Phase III Pediatric Trial

Lilly's Omvoh® Achieves Sustained Remission in Crohn's Disease

Replicate Bio Publishes First-in-Human Data for Rabies Vaccine

Bio-Thera Solutions Announces EU Filing for BAT2506 Biosimilar

CSL Behring's Hemgenix® Shows Sustained Efficacy in Hemophilia B

Roche's Gazyva Shows Superiority in Lupus Nephritis in NEJM

Epitopea Appoints Klaus Edvardsen as Chief Medical Officer

Taysha Gene Announces Inducement Grant Under Nasdaq LR 5635(c)(4)

Belgian regulator recommends blocking Indian API production

Driving Innovation in High Potent APIs

Ethical Veterinary APIs: Health, Safety, Sustainability

Alivus Life Sciences delivers 12% revenue growth

CCI clears merger of nine pharma entities with Sequent Scientific

Carbogen Amcis Passes Swissmedic Inspection Of Vionnaz Facility

Supriya opens new API block at Lote Parshuram site in Maharashtra

Alembic Pharma Panelav unit clears Brazil GMP audit

HPAPI for Drug Development and Delivery

Smallcap Pharma Stock Soars 10% On High Demand API Filing

FDA warns of allergic reactions with multiple sclerosis drugs

Laurus Labs' arm gets Form 483 from FDA 'adverse experience' probe

Cipla Goa facility receives form 483 with 1 observation

Hologic receives warning letter over Biozorb implantable marker

FDA boosts Philips cardiac monitor recall over missed ECG alerts

FDA Data Issues Lead To CRL, Warning Letter, Shareholder Lawsuit

US FDA classifies Biocon Biologics site as VAI

J&J pauses Varipulse US debut following 4 reports of strokes

FDA warning letter reveals production errors at Viatris plant

Spurious drugs worth Rs. 6.60 cr seized in Kolkata

IHH Healthcare Seeks Damages from Daiichi Sankyo for Fortis Offer

Hospital PMI® at 53.5%; January 2025 Hospital ISM® On Business®

Procept BioRobotics® to Report Q4 2024 Results on Feb 25, 2025